Hyun-Jung Sung

Title: Hyun-Jung Sung: Innovator in Antibacterial Agents

Introduction

Hyun-Jung Sung is a notable inventor based in Gyeonggi-do, South Korea. He has made significant contributions to the field of medicinal chemistry, particularly in the development of antibacterial agents. With a total of 4 patents to his name, his work has the potential to impact the treatment of bacterial infections.

Latest Patents

One of his latest patents involves tetrahydropyridine derivatives and their use as antibacterial agents. This patent describes a novel tetrahydropyridine derivative compound, including its stereoisomers and pharmaceutically acceptable salts. The methods outlined in this patent focus on inhibiting UDP-3-O—(R-3-hydroxymyristoyl)-N-acetylglucosamine deacetylase (LpxC) and treating Gram-negative bacterial infections. The compounds presented can exhibit excellent effects in treating such infections. Another significant patent is for a tricyclic benzoxaborole compound, which includes a preparation method and its use in antibiotic pharmaceutical compositions.

Career Highlights

Hyun-Jung Sung has worked with reputable companies such as Dong-a Pharm. Co., Ltd. and Dong-a St Co., Ltd. His experience in these organizations has contributed to his expertise in developing innovative pharmaceutical solutions.

Collaborations

He has collaborated with notable coworkers, including Sung-Hak Choi and Weon-Bin Im, who have also contributed to advancements in the field of medicinal chemistry.

Conclusion

Hyun-Jung Sung's innovative work in developing antibacterial agents showcases his commitment to addressing critical health challenges. His patents reflect a dedication to improving therapeutic options for bacterial infections.